Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Autonomic Nervous System Diseases | 47 | 2023 | 269 | 9.030 |
Why?
|
Diabetic Neuropathies | 43 | 2022 | 406 | 6.690 |
Why?
|
Hypotension, Orthostatic | 32 | 2021 | 256 | 6.370 |
Why?
|
Neuralgia | 21 | 2023 | 600 | 4.380 |
Why?
|
Autonomic Nervous System | 29 | 2023 | 697 | 4.030 |
Why?
|
Postural Orthostatic Tachycardia Syndrome | 11 | 2021 | 51 | 3.430 |
Why?
|
Peripheral Nervous System Diseases | 16 | 2024 | 708 | 3.320 |
Why?
|
alpha-Synuclein | 15 | 2024 | 749 | 3.190 |
Why?
|
Multiple System Atrophy | 17 | 2024 | 129 | 2.660 |
Why?
|
Skin | 24 | 2024 | 4466 | 2.470 |
Why?
|
Parkinson Disease | 20 | 2024 | 2859 | 2.070 |
Why?
|
Nerve Fibers | 10 | 2021 | 708 | 2.050 |
Why?
|
Syncope, Vasovagal | 8 | 2011 | 38 | 1.850 |
Why?
|
Pure Autonomic Failure | 7 | 2024 | 16 | 1.760 |
Why?
|
Polyneuropathies | 6 | 2021 | 137 | 1.750 |
Why?
|
Posture | 18 | 2021 | 953 | 1.730 |
Why?
|
Amyloid Neuropathies, Familial | 4 | 2022 | 150 | 1.700 |
Why?
|
Blood Pressure | 39 | 2022 | 8525 | 1.680 |
Why?
|
Baroreflex | 11 | 2023 | 148 | 1.670 |
Why?
|
Sympathetic Nervous System | 10 | 2022 | 520 | 1.570 |
Why?
|
Heart Rate | 31 | 2022 | 4179 | 1.570 |
Why?
|
Hypoglycemia | 9 | 2023 | 888 | 1.520 |
Why?
|
Droxidopa | 8 | 2014 | 10 | 1.400 |
Why?
|
Neuralgia, Postherpetic | 6 | 2021 | 41 | 1.320 |
Why?
|
Norepinephrine | 8 | 2015 | 900 | 1.210 |
Why?
|
Pain Threshold | 4 | 2020 | 603 | 1.200 |
Why?
|
Analgesics | 11 | 2023 | 1065 | 1.190 |
Why?
|
Autoimmune Diseases of the Nervous System | 4 | 2011 | 75 | 1.180 |
Why?
|
Pain Measurement | 22 | 2022 | 3528 | 1.160 |
Why?
|
Tilt-Table Test | 17 | 2021 | 79 | 1.150 |
Why?
|
Sweat Glands | 4 | 2011 | 33 | 1.090 |
Why?
|
Ganglia, Autonomic | 4 | 2011 | 43 | 1.080 |
Why?
|
Epidermis | 3 | 2020 | 529 | 1.020 |
Why?
|
Autonomic Pathways | 3 | 2020 | 31 | 0.990 |
Why?
|
Nerve Fibers, Unmyelinated | 3 | 2020 | 97 | 0.980 |
Why?
|
Paresthesia | 2 | 2020 | 162 | 0.960 |
Why?
|
Therapies, Investigational | 2 | 2014 | 112 | 0.890 |
Why?
|
Hyperalgesia | 3 | 2020 | 530 | 0.850 |
Why?
|
Sweating | 4 | 2008 | 154 | 0.820 |
Why?
|
Neurologic Examination | 8 | 2019 | 916 | 0.800 |
Why?
|
Reflex | 5 | 2012 | 376 | 0.780 |
Why?
|
gamma-Aminobutyric Acid | 6 | 2017 | 1132 | 0.730 |
Why?
|
Cannabinoids | 1 | 2023 | 173 | 0.730 |
Why?
|
Complex Regional Pain Syndromes | 2 | 2019 | 121 | 0.720 |
Why?
|
Hypesthesia | 1 | 2020 | 107 | 0.700 |
Why?
|
Fatigue Syndrome, Chronic | 5 | 2020 | 215 | 0.670 |
Why?
|
Humans | 214 | 2024 | 760621 | 0.650 |
Why?
|
Glucose Clamp Technique | 5 | 2023 | 263 | 0.650 |
Why?
|
Tachycardia | 4 | 2007 | 602 | 0.640 |
Why?
|
Biopsy | 10 | 2024 | 6771 | 0.640 |
Why?
|
Diagnostic Self Evaluation | 1 | 2020 | 225 | 0.610 |
Why?
|
Trigeminal Neuralgia | 1 | 2018 | 106 | 0.590 |
Why?
|
Prealbumin | 1 | 2019 | 222 | 0.570 |
Why?
|
Hereditary Sensory and Autonomic Neuropathies | 2 | 2015 | 41 | 0.560 |
Why?
|
Primary Dysautonomias | 3 | 2021 | 28 | 0.560 |
Why?
|
Sympathetic Fibers, Postganglionic | 3 | 2019 | 14 | 0.560 |
Why?
|
Antiparkinson Agents | 6 | 2017 | 183 | 0.560 |
Why?
|
Medical Informatics Applications | 1 | 2018 | 178 | 0.540 |
Why?
|
Lewy Body Disease | 5 | 2024 | 252 | 0.540 |
Why?
|
Peroneal Nerve | 3 | 2007 | 76 | 0.530 |
Why?
|
Nerve Degeneration | 5 | 2024 | 748 | 0.530 |
Why?
|
Cardiovascular Physiological Phenomena | 3 | 2013 | 239 | 0.530 |
Why?
|
Valsalva Maneuver | 9 | 2010 | 99 | 0.510 |
Why?
|
Neurodegenerative Diseases | 3 | 2021 | 1084 | 0.510 |
Why?
|
Cyclohexanecarboxylic Acids | 2 | 2017 | 140 | 0.500 |
Why?
|
Central Nervous System Diseases | 1 | 2020 | 521 | 0.500 |
Why?
|
Genetic Diseases, Inborn | 1 | 2020 | 601 | 0.490 |
Why?
|
Axons | 5 | 2024 | 1673 | 0.490 |
Why?
|
Cardiovascular System | 5 | 2015 | 850 | 0.490 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2020 | 952 | 0.490 |
Why?
|
Diabetes Mellitus | 9 | 2021 | 5889 | 0.480 |
Why?
|
Neural Conduction | 6 | 2020 | 441 | 0.480 |
Why?
|
Consensus | 12 | 2023 | 3113 | 0.480 |
Why?
|
Amines | 2 | 2017 | 281 | 0.480 |
Why?
|
Skin Physiological Phenomena | 2 | 2012 | 188 | 0.460 |
Why?
|
Activities of Daily Living | 3 | 2021 | 2417 | 0.450 |
Why?
|
Peripheral Nerves | 3 | 2020 | 475 | 0.450 |
Why?
|
Exercise Therapy | 1 | 2021 | 919 | 0.450 |
Why?
|
Middle Aged | 74 | 2024 | 220352 | 0.440 |
Why?
|
Midodrine | 2 | 2011 | 24 | 0.430 |
Why?
|
Piloerection | 1 | 2012 | 5 | 0.430 |
Why?
|
Parasympathetic Nervous System | 5 | 2008 | 141 | 0.430 |
Why?
|
Autopsy | 1 | 2017 | 1007 | 0.430 |
Why?
|
Orthostatic Intolerance | 3 | 2021 | 22 | 0.420 |
Why?
|
Hyperhidrosis | 2 | 2008 | 34 | 0.420 |
Why?
|
Persian Gulf Syndrome | 1 | 2013 | 47 | 0.420 |
Why?
|
Blood Volume | 4 | 2018 | 550 | 0.410 |
Why?
|
Male | 93 | 2024 | 359744 | 0.410 |
Why?
|
Neurology | 5 | 2021 | 779 | 0.410 |
Why?
|
Quality of Life | 10 | 2022 | 13308 | 0.410 |
Why?
|
Electrodiagnosis | 3 | 2020 | 148 | 0.410 |
Why?
|
Capsaicin | 2 | 2010 | 231 | 0.400 |
Why?
|
Adrenergic alpha-1 Receptor Agonists | 1 | 2011 | 18 | 0.400 |
Why?
|
Nervous System Diseases | 4 | 2020 | 1647 | 0.400 |
Why?
|
Sensory Receptor Cells | 2 | 2009 | 509 | 0.400 |
Why?
|
Respiration | 6 | 2013 | 1654 | 0.390 |
Why?
|
Syncope | 4 | 2020 | 428 | 0.390 |
Why?
|
Female | 90 | 2024 | 391270 | 0.380 |
Why?
|
Vasodilation | 4 | 2010 | 962 | 0.380 |
Why?
|
Societies, Medical | 4 | 2020 | 3905 | 0.370 |
Why?
|
Adult | 69 | 2024 | 219994 | 0.370 |
Why?
|
Sensory System Agents | 1 | 2010 | 21 | 0.370 |
Why?
|
Forearm | 5 | 2008 | 429 | 0.360 |
Why?
|
Practice Guidelines as Topic | 4 | 2020 | 7475 | 0.350 |
Why?
|
Iontophoresis | 5 | 2012 | 74 | 0.340 |
Why?
|
Double-Blind Method | 17 | 2021 | 12427 | 0.330 |
Why?
|
Papillomavirus Vaccines | 3 | 2020 | 495 | 0.330 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2014 | 1347 | 0.330 |
Why?
|
Pain | 7 | 2023 | 5066 | 0.330 |
Why?
|
Mycophenolic Acid | 2 | 2009 | 343 | 0.320 |
Why?
|
Blood Pressure Determination | 4 | 2021 | 640 | 0.320 |
Why?
|
Sympathomimetics | 2 | 2008 | 56 | 0.310 |
Why?
|
Receptors, Nicotinic | 2 | 2009 | 494 | 0.300 |
Why?
|
Tramadol | 2 | 2017 | 60 | 0.300 |
Why?
|
Biomedical Research | 2 | 2014 | 3426 | 0.300 |
Why?
|
Anticonvulsants | 3 | 2007 | 1879 | 0.300 |
Why?
|
Clinical Trials as Topic | 4 | 2019 | 8056 | 0.300 |
Why?
|
Vasodilator Agents | 4 | 2012 | 978 | 0.300 |
Why?
|
Aged | 46 | 2024 | 169152 | 0.300 |
Why?
|
Hypoglycemic Agents | 4 | 2023 | 3150 | 0.300 |
Why?
|
Plasmapheresis | 1 | 2008 | 206 | 0.290 |
Why?
|
Blood Glucose | 5 | 2023 | 6381 | 0.280 |
Why?
|
Vagus Nerve | 2 | 2015 | 458 | 0.280 |
Why?
|
Reference Values | 13 | 2013 | 4925 | 0.280 |
Why?
|
Stress, Physiological | 2 | 2024 | 1398 | 0.280 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2021 | 10344 | 0.270 |
Why?
|
Clinical Trials, Phase II as Topic | 2 | 2019 | 629 | 0.270 |
Why?
|
Prednisone | 2 | 2009 | 1565 | 0.270 |
Why?
|
Reflex, Abnormal | 2 | 2015 | 83 | 0.270 |
Why?
|
Insulin | 5 | 2023 | 6597 | 0.270 |
Why?
|
Shy-Drager Syndrome | 4 | 2019 | 9 | 0.270 |
Why?
|
Pathology | 1 | 2009 | 270 | 0.260 |
Why?
|
Diabetes Complications | 3 | 2009 | 1341 | 0.260 |
Why?
|
Autoantibodies | 4 | 2009 | 2118 | 0.260 |
Why?
|
Acetylcholine | 3 | 2006 | 629 | 0.260 |
Why?
|
Aldosterone | 1 | 2010 | 868 | 0.260 |
Why?
|
Sensation | 4 | 2013 | 331 | 0.260 |
Why?
|
Diabetic Angiopathies | 2 | 2003 | 822 | 0.250 |
Why?
|
Nociceptors | 2 | 2006 | 457 | 0.250 |
Why?
|
Methoxyhydroxyphenylglycol | 1 | 2004 | 93 | 0.250 |
Why?
|
Fructose | 1 | 2007 | 287 | 0.240 |
Why?
|
Analysis of Variance | 8 | 2011 | 6238 | 0.240 |
Why?
|
Pressoreceptors | 1 | 2004 | 100 | 0.240 |
Why?
|
Autoantigens | 1 | 2009 | 877 | 0.240 |
Why?
|
Sweat Gland Diseases | 1 | 2003 | 12 | 0.230 |
Why?
|
Thioctic Acid | 2 | 2015 | 28 | 0.230 |
Why?
|
Microcirculation | 4 | 2003 | 1278 | 0.220 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2007 | 370 | 0.220 |
Why?
|
Nerve Growth Factors | 2 | 2013 | 562 | 0.220 |
Why?
|
Public-Private Sector Partnerships | 3 | 2021 | 122 | 0.220 |
Why?
|
Amyloidosis | 3 | 2008 | 817 | 0.220 |
Why?
|
Bloodletting | 1 | 2003 | 23 | 0.220 |
Why?
|
Single-Blind Method | 2 | 2024 | 1578 | 0.220 |
Why?
|
Factitious Disorders | 1 | 2003 | 39 | 0.210 |
Why?
|
Phosphorylation | 3 | 2024 | 8313 | 0.210 |
Why?
|
Acetaminophen | 1 | 2007 | 553 | 0.210 |
Why?
|
Galvanic Skin Response | 2 | 2020 | 348 | 0.210 |
Why?
|
Dizziness | 4 | 2020 | 257 | 0.200 |
Why?
|
Population Surveillance | 1 | 2013 | 2608 | 0.200 |
Why?
|
Disease Progression | 9 | 2024 | 13502 | 0.200 |
Why?
|
Solitary Nucleus | 1 | 2022 | 55 | 0.200 |
Why?
|
Treatment Outcome | 23 | 2021 | 65017 | 0.200 |
Why?
|
Societies, Scientific | 2 | 2020 | 221 | 0.200 |
Why?
|
Nitroprusside | 3 | 2012 | 273 | 0.200 |
Why?
|
Vincristine | 1 | 2024 | 1039 | 0.200 |
Why?
|
Sensation Disorders | 1 | 2003 | 160 | 0.200 |
Why?
|
Sensory Thresholds | 3 | 2017 | 377 | 0.200 |
Why?
|
Carbamates | 2 | 2013 | 192 | 0.200 |
Why?
|
Neuromuscular Diseases | 1 | 2004 | 256 | 0.190 |
Why?
|
Leukocyte Rolling | 1 | 2021 | 69 | 0.190 |
Why?
|
Hypotension | 4 | 2007 | 883 | 0.190 |
Why?
|
Technology Assessment, Biomedical | 1 | 2004 | 306 | 0.190 |
Why?
|
Hypohidrosis | 2 | 2009 | 29 | 0.190 |
Why?
|
Head-Down Tilt | 2 | 1997 | 66 | 0.180 |
Why?
|
Electric Stimulation | 3 | 2013 | 1735 | 0.180 |
Why?
|
Macrophages, Peritoneal | 1 | 2021 | 237 | 0.180 |
Why?
|
REM Sleep Behavior Disorder | 1 | 2021 | 108 | 0.180 |
Why?
|
Anal Canal | 1 | 2003 | 372 | 0.180 |
Why?
|
Pituitary-Adrenal System | 1 | 2024 | 552 | 0.180 |
Why?
|
Cosyntropin | 1 | 2020 | 34 | 0.180 |
Why?
|
Receptors, Mineralocorticoid | 1 | 2021 | 164 | 0.180 |
Why?
|
Systole | 2 | 2020 | 947 | 0.180 |
Why?
|
Cross-Over Studies | 5 | 2020 | 2061 | 0.170 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2020 | 169 | 0.170 |
Why?
|
Vasomotor System | 1 | 2020 | 207 | 0.170 |
Why?
|
Aged, 80 and over | 14 | 2024 | 58995 | 0.170 |
Why?
|
Electromyography | 2 | 2003 | 1388 | 0.170 |
Why?
|
Flushing | 2 | 2006 | 52 | 0.170 |
Why?
|
Silicones | 2 | 2012 | 227 | 0.170 |
Why?
|
Reproducibility of Results | 5 | 2024 | 20080 | 0.170 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2024 | 700 | 0.170 |
Why?
|
Muscle, Smooth | 2 | 2019 | 924 | 0.170 |
Why?
|
Regional Blood Flow | 4 | 2006 | 1490 | 0.170 |
Why?
|
Vasoconstrictor Agents | 3 | 2012 | 651 | 0.170 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 25942 | 0.160 |
Why?
|
Young Adult | 14 | 2024 | 58741 | 0.160 |
Why?
|
Veterans | 1 | 2013 | 2642 | 0.160 |
Why?
|
Immunosuppressive Agents | 3 | 2009 | 4166 | 0.160 |
Why?
|
Partnership Practice | 1 | 2018 | 14 | 0.160 |
Why?
|
Diabetic Nephropathies | 1 | 2006 | 988 | 0.160 |
Why?
|
History, 17th Century | 2 | 2013 | 107 | 0.160 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2019 | 861 | 0.160 |
Why?
|
Phenylephrine | 2 | 2012 | 293 | 0.160 |
Why?
|
Hemodynamics | 4 | 2021 | 4174 | 0.160 |
Why?
|
Levodopa | 1 | 2019 | 217 | 0.150 |
Why?
|
History, 18th Century | 2 | 2013 | 207 | 0.150 |
Why?
|
Analgesics, Opioid | 2 | 2021 | 3763 | 0.150 |
Why?
|
Severity of Illness Index | 7 | 2021 | 15840 | 0.150 |
Why?
|
Attitude | 1 | 2023 | 777 | 0.150 |
Why?
|
Diagnosis, Differential | 5 | 2021 | 12965 | 0.150 |
Why?
|
Veins | 1 | 2002 | 765 | 0.150 |
Why?
|
Lidocaine | 3 | 2017 | 538 | 0.150 |
Why?
|
Extremities | 1 | 2003 | 867 | 0.150 |
Why?
|
Epinephrine | 3 | 2023 | 791 | 0.150 |
Why?
|
Papillomavirus Infections | 2 | 2019 | 1607 | 0.150 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2021 | 378 | 0.150 |
Why?
|
Congresses as Topic | 2 | 2019 | 805 | 0.140 |
Why?
|
Amyloid | 1 | 2022 | 842 | 0.140 |
Why?
|
Foot | 2 | 1998 | 573 | 0.140 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 1999 | 326 | 0.140 |
Why?
|
Dystonic Disorders | 1 | 2021 | 340 | 0.140 |
Why?
|
Pruritus | 1 | 2020 | 377 | 0.140 |
Why?
|
Paclitaxel | 1 | 2024 | 1736 | 0.140 |
Why?
|
Celiac Disease | 1 | 2005 | 822 | 0.140 |
Why?
|
Dyspnea | 1 | 2005 | 1352 | 0.140 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2011 | 454 | 0.140 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 587 | 0.140 |
Why?
|
Organoplatinum Compounds | 1 | 2018 | 410 | 0.140 |
Why?
|
Unconsciousness | 3 | 2021 | 251 | 0.140 |
Why?
|
Sjogren's Syndrome | 2 | 2009 | 235 | 0.140 |
Why?
|
Sex Characteristics | 1 | 2007 | 2629 | 0.140 |
Why?
|
Electrocardiography | 6 | 2017 | 6414 | 0.140 |
Why?
|
Cardiovascular Diseases | 6 | 2011 | 15757 | 0.130 |
Why?
|
Epilepsy | 2 | 2006 | 3267 | 0.130 |
Why?
|
Microvessels | 1 | 2020 | 572 | 0.130 |
Why?
|
Paraffin Embedding | 1 | 2017 | 302 | 0.130 |
Why?
|
Spectrum Analysis | 2 | 2004 | 453 | 0.130 |
Why?
|
Neurophysiology | 2 | 2020 | 144 | 0.130 |
Why?
|
Vasoconstriction | 1 | 2018 | 593 | 0.130 |
Why?
|
Antioxidants | 2 | 2015 | 1667 | 0.130 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2014 | 10827 | 0.130 |
Why?
|
Cell Count | 2 | 2010 | 1835 | 0.130 |
Why?
|
Aortic Diseases | 1 | 2021 | 736 | 0.130 |
Why?
|
Prospective Studies | 8 | 2024 | 54303 | 0.130 |
Why?
|
Oxygen Consumption | 1 | 2002 | 1843 | 0.130 |
Why?
|
Longitudinal Studies | 6 | 2024 | 14495 | 0.130 |
Why?
|
Arrhythmia, Sinus | 1 | 1995 | 48 | 0.120 |
Why?
|
Cerebral Arteries | 1 | 1997 | 493 | 0.120 |
Why?
|
Animals | 17 | 2022 | 167963 | 0.120 |
Why?
|
Aorta, Thoracic | 1 | 2021 | 1097 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 8 | 2023 | 12293 | 0.120 |
Why?
|
Nitric Oxide Synthase | 1 | 1998 | 908 | 0.120 |
Why?
|
Placebos | 2 | 2011 | 1668 | 0.120 |
Why?
|
Cell Adhesion | 1 | 2021 | 3094 | 0.120 |
Why?
|
Autonomic Agents | 1 | 2014 | 7 | 0.120 |
Why?
|
Patient Participation | 1 | 2023 | 1439 | 0.120 |
Why?
|
Urinary Bladder Diseases | 2 | 2011 | 169 | 0.120 |
Why?
|
Reaction Time | 3 | 2012 | 2075 | 0.120 |
Why?
|
Time Factors | 7 | 2016 | 40165 | 0.110 |
Why?
|
Diabetic Foot | 1 | 1998 | 381 | 0.110 |
Why?
|
Blood Flow Velocity | 1 | 1997 | 1377 | 0.110 |
Why?
|
Adrenergic Agents | 2 | 2023 | 74 | 0.110 |
Why?
|
Laser-Doppler Flowmetry | 2 | 2010 | 239 | 0.110 |
Why?
|
Papillomaviridae | 1 | 2019 | 1117 | 0.110 |
Why?
|
Antidepressive Agents | 1 | 2005 | 2890 | 0.110 |
Why?
|
Heart Function Tests | 2 | 1997 | 319 | 0.110 |
Why?
|
Compliance | 2 | 2003 | 100 | 0.110 |
Why?
|
Cholinergic Antagonists | 2 | 2004 | 164 | 0.110 |
Why?
|
Supine Position | 3 | 2019 | 205 | 0.110 |
Why?
|
Antibodies | 2 | 2011 | 2421 | 0.110 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2013 | 62 | 0.110 |
Why?
|
Expert Testimony | 1 | 2015 | 361 | 0.110 |
Why?
|
Erythromelalgia | 1 | 1992 | 15 | 0.110 |
Why?
|
Clinical Protocols | 1 | 2019 | 1440 | 0.110 |
Why?
|
Plasma Exchange | 2 | 2011 | 158 | 0.110 |
Why?
|
Catecholamines | 3 | 2015 | 385 | 0.100 |
Why?
|
Reflex Sympathetic Dystrophy | 1 | 1992 | 58 | 0.100 |
Why?
|
HIV Infections | 2 | 2016 | 17165 | 0.100 |
Why?
|
Monocytes | 1 | 2021 | 2575 | 0.100 |
Why?
|
Models, Cardiovascular | 2 | 1999 | 978 | 0.100 |
Why?
|
Delphi Technique | 1 | 2015 | 829 | 0.100 |
Why?
|
Diabetes Mellitus, Type 1 | 7 | 2013 | 3455 | 0.100 |
Why?
|
Rifampin | 1 | 2014 | 340 | 0.100 |
Why?
|
Hypertension | 4 | 2020 | 8594 | 0.100 |
Why?
|
Endothelium, Vascular | 2 | 2003 | 4433 | 0.100 |
Why?
|
Group Processes | 1 | 2013 | 226 | 0.100 |
Why?
|
Prodrugs | 1 | 2013 | 259 | 0.100 |
Why?
|
Delayed-Action Preparations | 1 | 2015 | 961 | 0.100 |
Why?
|
Iatrogenic Disease | 1 | 2014 | 538 | 0.100 |
Why?
|
Equidae | 1 | 2011 | 10 | 0.090 |
Why?
|
Receptors, Cholinergic | 1 | 2011 | 244 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1846 | 0.090 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2005 | 784 | 0.090 |
Why?
|
Membrane Glycoproteins | 1 | 2021 | 3707 | 0.090 |
Why?
|
AIDS-Related Complex | 1 | 1990 | 107 | 0.090 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 2011 | 180 | 0.090 |
Why?
|
Research Design | 5 | 2023 | 6180 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2020 | 2061 | 0.090 |
Why?
|
Somatoform Disorders | 1 | 2013 | 423 | 0.090 |
Why?
|
Case-Control Studies | 4 | 2020 | 22053 | 0.090 |
Why?
|
Proteomics | 1 | 2023 | 3817 | 0.090 |
Why?
|
Retrospective Studies | 8 | 2021 | 80372 | 0.080 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2011 | 370 | 0.080 |
Why?
|
Heart | 1 | 2003 | 4393 | 0.080 |
Why?
|
Syndrome | 2 | 2007 | 3280 | 0.080 |
Why?
|
History, 19th Century | 2 | 2003 | 720 | 0.080 |
Why?
|
Wallerian Degeneration | 1 | 2009 | 68 | 0.080 |
Why?
|
International Cooperation | 1 | 2015 | 1433 | 0.080 |
Why?
|
Predictive Value of Tests | 3 | 2016 | 15289 | 0.080 |
Why?
|
Pupil Disorders | 1 | 2009 | 32 | 0.080 |
Why?
|
Cross Reactions | 1 | 2011 | 818 | 0.080 |
Why?
|
Administration, Topical | 1 | 2010 | 697 | 0.080 |
Why?
|
Cohort Studies | 6 | 2024 | 41335 | 0.080 |
Why?
|
Fludrocortisone | 1 | 2008 | 24 | 0.080 |
Why?
|
Exercise | 2 | 2002 | 5787 | 0.080 |
Why?
|
Cytological Techniques | 1 | 2010 | 218 | 0.080 |
Why?
|
Hematocrit | 2 | 2002 | 629 | 0.080 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2011 | 314 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2315 | 0.080 |
Why?
|
Isometric Contraction | 2 | 2004 | 146 | 0.080 |
Why?
|
Adolescent | 8 | 2024 | 87810 | 0.080 |
Why?
|
Blood Vessels | 2 | 2005 | 1112 | 0.080 |
Why?
|
Erectile Dysfunction | 1 | 2011 | 452 | 0.070 |
Why?
|
Automation | 1 | 2010 | 580 | 0.070 |
Why?
|
Urination Disorders | 1 | 2009 | 240 | 0.070 |
Why?
|
Boston | 1 | 2020 | 9280 | 0.070 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2021 | 791 | 0.070 |
Why?
|
Anesthetics | 1 | 2013 | 522 | 0.070 |
Why?
|
Amyloid Neuropathies | 1 | 2007 | 15 | 0.070 |
Why?
|
Physical Stimulation | 2 | 2013 | 518 | 0.070 |
Why?
|
Electric Stimulation Therapy | 1 | 2013 | 613 | 0.070 |
Why?
|
Data Interpretation, Statistical | 2 | 2008 | 2696 | 0.070 |
Why?
|
Sural Nerve | 1 | 2007 | 105 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2013 | 2362 | 0.070 |
Why?
|
Follow-Up Studies | 7 | 2017 | 39261 | 0.070 |
Why?
|
Ulnar Nerve | 1 | 2007 | 102 | 0.070 |
Why?
|
United States | 10 | 2021 | 72461 | 0.070 |
Why?
|
Vasopressins | 1 | 2008 | 355 | 0.070 |
Why?
|
Prevalence | 5 | 2017 | 15687 | 0.070 |
Why?
|
Species Specificity | 1 | 2011 | 2418 | 0.070 |
Why?
|
Tablets | 1 | 2007 | 149 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2471 | 0.070 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2008 | 297 | 0.070 |
Why?
|
Drug Tolerance | 1 | 2008 | 369 | 0.070 |
Why?
|
Body Composition | 1 | 1995 | 2419 | 0.070 |
Why?
|
Vascular Diseases | 1 | 2014 | 1182 | 0.070 |
Why?
|
Renin-Angiotensin System | 1 | 2010 | 738 | 0.070 |
Why?
|
Adrenergic Agonists | 1 | 2005 | 58 | 0.060 |
Why?
|
Anesthetics, Local | 1 | 2012 | 1001 | 0.060 |
Why?
|
Psychophysics | 2 | 2019 | 289 | 0.060 |
Why?
|
Attention | 2 | 2016 | 2387 | 0.060 |
Why?
|
Guillain-Barre Syndrome | 1 | 2007 | 125 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2021 | 3517 | 0.060 |
Why?
|
Gliadin | 1 | 2005 | 80 | 0.060 |
Why?
|
Disopyramide | 1 | 2004 | 16 | 0.060 |
Why?
|
Drinking | 2 | 2004 | 199 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13630 | 0.060 |
Why?
|
Linear Models | 2 | 2006 | 5877 | 0.060 |
Why?
|
Constriction | 1 | 2004 | 172 | 0.060 |
Why?
|
Body Weight | 1 | 1995 | 4611 | 0.060 |
Why?
|
Drug Administration Schedule | 2 | 2014 | 4899 | 0.060 |
Why?
|
Theophylline | 1 | 2004 | 131 | 0.060 |
Why?
|
Rabbits | 1 | 2011 | 4773 | 0.060 |
Why?
|
Brain | 5 | 2022 | 26951 | 0.060 |
Why?
|
Skin Temperature | 1 | 2004 | 96 | 0.060 |
Why?
|
Diastole | 2 | 2017 | 788 | 0.060 |
Why?
|
Lewy Bodies | 1 | 2004 | 144 | 0.060 |
Why?
|
Models, Neurological | 1 | 2012 | 1758 | 0.060 |
Why?
|
Cold Temperature | 2 | 2003 | 780 | 0.060 |
Why?
|
Constipation | 1 | 2009 | 561 | 0.060 |
Why?
|
Medical History Taking | 1 | 2008 | 773 | 0.060 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2004 | 132 | 0.060 |
Why?
|
Skin Diseases | 1 | 1992 | 1089 | 0.060 |
Why?
|
Phenotype | 4 | 2022 | 16546 | 0.060 |
Why?
|
Death, Sudden | 1 | 2006 | 302 | 0.060 |
Why?
|
Carbidopa | 1 | 2003 | 30 | 0.060 |
Why?
|
Aromatic-L-Amino-Acid Decarboxylases | 1 | 2003 | 27 | 0.060 |
Why?
|
Half-Life | 1 | 2004 | 652 | 0.060 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2003 | 33 | 0.060 |
Why?
|
Sodium Channels | 1 | 2005 | 344 | 0.060 |
Why?
|
Psychomotor Performance | 1 | 2011 | 1878 | 0.050 |
Why?
|
Cardiology | 1 | 1995 | 1723 | 0.050 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2005 | 432 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14660 | 0.050 |
Why?
|
MEDLINE | 1 | 2003 | 119 | 0.050 |
Why?
|
History, Medieval | 1 | 2003 | 62 | 0.050 |
Why?
|
History, 16th Century | 1 | 2003 | 70 | 0.050 |
Why?
|
Neuropsychological Tests | 2 | 2016 | 7021 | 0.050 |
Why?
|
Thermosensing | 1 | 2003 | 55 | 0.050 |
Why?
|
Gastrointestinal Diseases | 1 | 2011 | 1190 | 0.050 |
Why?
|
Microscopy, Confocal | 2 | 2020 | 1972 | 0.050 |
Why?
|
Clinical Laboratory Techniques | 1 | 2008 | 749 | 0.050 |
Why?
|
Acupuncture Therapy | 1 | 2007 | 480 | 0.050 |
Why?
|
Body Temperature Regulation | 1 | 2004 | 286 | 0.050 |
Why?
|
Diet, Sodium-Restricted | 1 | 2004 | 291 | 0.050 |
Why?
|
History, Ancient | 1 | 2003 | 211 | 0.050 |
Why?
|
Registries | 1 | 2019 | 8469 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2016 | 3976 | 0.050 |
Why?
|
Prilocaine | 1 | 2002 | 21 | 0.050 |
Why?
|
Plethysmography | 1 | 2002 | 174 | 0.050 |
Why?
|
Algorithms | 2 | 2018 | 13981 | 0.050 |
Why?
|
Nausea | 1 | 2005 | 678 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2803 | 0.050 |
Why?
|
Decompression, Surgical | 1 | 2007 | 604 | 0.050 |
Why?
|
Pilot Projects | 2 | 2012 | 8555 | 0.050 |
Why?
|
Immunoglobulin A | 1 | 2005 | 979 | 0.050 |
Why?
|
Health Surveys | 1 | 2011 | 4063 | 0.050 |
Why?
|
Ankyrins | 1 | 2021 | 123 | 0.050 |
Why?
|
U937 Cells | 1 | 2021 | 262 | 0.050 |
Why?
|
Extracellular Space | 1 | 2003 | 564 | 0.050 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1990 | 2197 | 0.050 |
Why?
|
Survival Rate | 1 | 2015 | 12808 | 0.050 |
Why?
|
Bradycardia | 1 | 2003 | 299 | 0.050 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2021 | 102 | 0.050 |
Why?
|
Vibration | 1 | 2003 | 327 | 0.050 |
Why?
|
Medulla Oblongata | 1 | 2022 | 248 | 0.050 |
Why?
|
Drug Combinations | 1 | 2007 | 2025 | 0.050 |
Why?
|
Receptors, GABA | 1 | 2022 | 305 | 0.050 |
Why?
|
Translations | 1 | 2020 | 81 | 0.040 |
Why?
|
Ureter | 1 | 2003 | 375 | 0.040 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2024 | 626 | 0.040 |
Why?
|
NAD | 1 | 2024 | 609 | 0.040 |
Why?
|
Plasma | 1 | 2023 | 584 | 0.040 |
Why?
|
Image Enhancement | 1 | 2011 | 2881 | 0.040 |
Why?
|
Mood Disorders | 1 | 2007 | 1124 | 0.040 |
Why?
|
Body Temperature | 1 | 2003 | 777 | 0.040 |
Why?
|
Isoquinolines | 1 | 2021 | 353 | 0.040 |
Why?
|
Sleep | 2 | 2007 | 4751 | 0.040 |
Why?
|
Endovascular Procedures | 1 | 2013 | 2165 | 0.040 |
Why?
|
England | 1 | 2001 | 526 | 0.040 |
Why?
|
Nerve Growth Factor | 1 | 2000 | 158 | 0.040 |
Why?
|
Computer Simulation | 1 | 1993 | 6218 | 0.040 |
Why?
|
Muscle, Skeletal | 2 | 2012 | 4925 | 0.040 |
Why?
|
Cardiac Output | 1 | 2002 | 838 | 0.040 |
Why?
|
Cell Death | 1 | 2004 | 1672 | 0.040 |
Why?
|
Chest Pain | 1 | 2006 | 1106 | 0.040 |
Why?
|
Optic Nerve Diseases | 1 | 2002 | 342 | 0.040 |
Why?
|
Abdomen | 1 | 2004 | 1130 | 0.040 |
Why?
|
Synaptic Transmission | 1 | 2004 | 1171 | 0.040 |
Why?
|
Anti-Inflammatory Agents | 1 | 2008 | 1796 | 0.040 |
Why?
|
Leg | 1 | 2003 | 1090 | 0.040 |
Why?
|
Stress, Psychological | 2 | 2024 | 4446 | 0.040 |
Why?
|
Nevada | 1 | 2017 | 22 | 0.040 |
Why?
|
Upper Extremity | 1 | 2003 | 661 | 0.040 |
Why?
|
Lung Volume Measurements | 1 | 1999 | 376 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2008 | 3215 | 0.040 |
Why?
|
Physical Fitness | 1 | 2002 | 732 | 0.040 |
Why?
|
Spironolactone | 1 | 2021 | 411 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17790 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 3726 | 0.040 |
Why?
|
Terminology as Topic | 1 | 2004 | 1535 | 0.040 |
Why?
|
Submandibular Gland | 1 | 2017 | 87 | 0.030 |
Why?
|
Capillaries | 1 | 2020 | 744 | 0.030 |
Why?
|
Brain Stem | 1 | 2022 | 857 | 0.030 |
Why?
|
Adrenergic alpha-Agonists | 1 | 1997 | 178 | 0.030 |
Why?
|
Vascular Resistance | 1 | 1999 | 933 | 0.030 |
Why?
|
Counseling | 1 | 2004 | 1548 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11071 | 0.030 |
Why?
|
PubMed | 1 | 2016 | 128 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2006 | 2255 | 0.030 |
Why?
|
Fractals | 1 | 1996 | 128 | 0.030 |
Why?
|
Patient Advocacy | 1 | 2017 | 358 | 0.030 |
Why?
|
Databases, Bibliographic | 1 | 2015 | 130 | 0.030 |
Why?
|
Administration, Oral | 1 | 2003 | 4035 | 0.030 |
Why?
|
Gastroparesis | 1 | 1997 | 137 | 0.030 |
Why?
|
Narcotics | 1 | 2017 | 336 | 0.030 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2017 | 170 | 0.030 |
Why?
|
History, 20th Century | 1 | 2003 | 2773 | 0.030 |
Why?
|
Benzhydryl Compounds | 1 | 2021 | 941 | 0.030 |
Why?
|
Prognosis | 4 | 2017 | 29658 | 0.030 |
Why?
|
Intermediate Filaments | 1 | 2015 | 172 | 0.030 |
Why?
|
Social Participation | 1 | 2016 | 183 | 0.030 |
Why?
|
Fatigue | 1 | 2002 | 1544 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2016 | 2852 | 0.030 |
Why?
|
United States Department of Agriculture | 1 | 2014 | 47 | 0.030 |
Why?
|
Mutation | 1 | 2019 | 29932 | 0.030 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2014 | 111 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1998 | 1173 | 0.030 |
Why?
|
Seizures | 1 | 2006 | 2917 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2020 | 2651 | 0.030 |
Why?
|
Laryngeal Neoplasms | 1 | 2016 | 514 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2000 | 6538 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1677 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2021 | 4264 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 12531 | 0.020 |
Why?
|
Body Mass Index | 2 | 2003 | 12914 | 0.020 |
Why?
|
Risk | 1 | 2003 | 9631 | 0.020 |
Why?
|
Gastrointestinal Motility | 1 | 1993 | 234 | 0.020 |
Why?
|
Virus Diseases | 1 | 1997 | 720 | 0.020 |
Why?
|
Homeostasis | 1 | 2022 | 3306 | 0.020 |
Why?
|
Anthropometry | 1 | 1995 | 1348 | 0.020 |
Why?
|
Disease Management | 2 | 2011 | 2514 | 0.020 |
Why?
|
Risk Factors | 2 | 2014 | 74359 | 0.020 |
Why?
|
Electrophysiology | 1 | 2013 | 1265 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2392 | 0.020 |
Why?
|
Mice | 2 | 2021 | 81208 | 0.020 |
Why?
|
Age of Onset | 1 | 2017 | 3301 | 0.020 |
Why?
|
Chronic Disease | 1 | 2004 | 9287 | 0.020 |
Why?
|
Models, Statistical | 1 | 2003 | 5075 | 0.020 |
Why?
|
Proteins | 1 | 2023 | 6029 | 0.020 |
Why?
|
Colon | 1 | 2017 | 1788 | 0.020 |
Why?
|
Intestinal Diseases | 1 | 1993 | 506 | 0.020 |
Why?
|
Executive Function | 1 | 2016 | 1374 | 0.020 |
Why?
|
Muscle Contraction | 1 | 1993 | 1201 | 0.020 |
Why?
|
Stroke Volume | 1 | 2002 | 5523 | 0.020 |
Why?
|
Research | 1 | 2016 | 1974 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2021 | 7593 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10547 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4283 | 0.020 |
Why?
|
Acupuncture Analgesia | 1 | 2007 | 63 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2019 | 3811 | 0.020 |
Why?
|
Memory | 1 | 2016 | 2179 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6498 | 0.020 |
Why?
|
Diet | 1 | 2004 | 8010 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2016 | 6015 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2008 | 618 | 0.020 |
Why?
|
Eating | 1 | 1993 | 1539 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 2011 | 786 | 0.020 |
Why?
|
Mental Disorders | 2 | 2013 | 6796 | 0.020 |
Why?
|
Aging | 2 | 1995 | 8651 | 0.020 |
Why?
|
Neurons | 1 | 2004 | 9426 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 1994 | 2164 | 0.010 |
Why?
|
Adipose Tissue | 1 | 1995 | 3301 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6465 | 0.010 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2013 | 1469 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22023 | 0.010 |
Why?
|
Sick Leave | 1 | 2003 | 105 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 1994 | 2571 | 0.010 |
Why?
|
Cuba | 1 | 2002 | 48 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18137 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3696 | 0.010 |
Why?
|
Demyelinating Diseases | 1 | 2003 | 351 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4024 | 0.010 |
Why?
|
Evoked Potentials, Motor | 1 | 2003 | 461 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18416 | 0.010 |
Why?
|
Cognition | 1 | 2017 | 6957 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2008 | 1803 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 24123 | 0.010 |
Why?
|
Coronary Disease | 1 | 1994 | 5990 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2008 | 1380 | 0.010 |
Why?
|
Comorbidity | 1 | 2014 | 10551 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23376 | 0.010 |
Why?
|
Normal Distribution | 1 | 1997 | 273 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2022 | 36290 | 0.010 |
Why?
|
Motor Neurons | 1 | 1998 | 865 | 0.010 |
Why?
|
Obesity | 1 | 1995 | 12922 | 0.010 |
Why?
|
Electrocardiography, Ambulatory | 1 | 1994 | 578 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2003 | 4541 | 0.010 |
Why?
|
Stroke | 1 | 2013 | 9962 | 0.010 |
Why?
|
Adrenal Medulla | 1 | 1989 | 56 | 0.010 |
Why?
|
Inflammation | 1 | 2008 | 10756 | 0.000 |
Why?
|
Neoplasms | 1 | 2017 | 22072 | 0.000 |
Why?
|
Incidence | 1 | 1994 | 21392 | 0.000 |
Why?
|